<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35145008</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-632X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>98</Volume>
            <Issue>14</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>Neurology</Title>
          <ISOAbbreviation>Neurology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pearls &amp; Oy-sters: Bilateral Mononeuropathic Neuralgic Amyotrophy Triggered by <i>Bartonella henselae</i> Infection Responsive to Immunoglobulin.</ArticleTitle>
        <Pagination>
          <StartPage>597</StartPage>
          <EndPage>600</EndPage>
          <MedlinePgn>597-600</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000200014</ELocationID>
        <Abstract>
          <AbstractText>We present a case of a cat owner with a scar on his right thenar eminence, followed by lymphadenopathy in the right axilla, general malaise and fever, and subsequent onset of bilateral neuralgic amyotrophy within one week. After a comprehensive workup, cat scratch disease caused by <i>Bartonella henselae</i> was confirmed serologically and adequately treated. Despite antibiotic treatment, the patient presented clinically with persistent bilateral, asymmetric neuropathy of the median nerve, predominantly the interosseous anterior nerve, which was confirmed by multifocal swelling and hyperintense signal of the nerves on T2-weighted MR neurography. Electrophysiological examination confirmed axonal median neuropathies bilaterally. After an unsuccessful steroid treatment trial, the patient showed an excellent and sustained response to intravenous immunoglobulin despite a delay from symptom onset to treatment of 10 months.</AbstractText>
          <CopyrightInformation>Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dietmann</LastName>
            <ForeName>Anelia</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-8949-0645</Identifier>
            <AffiliationInfo>
              <Affiliation>From the Departments of Neurology (A.D., G.T., T.R.M., O.S.) Infectious Diseases (E.C.-B.), Inselspital, Bern University Hospital, University of Bern, Switzerland. anelia.dietmann@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Colin-Benoit</LastName>
            <ForeName>Eugénie</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0001-6327-1949</Identifier>
            <AffiliationInfo>
              <Affiliation>From the Departments of Neurology (A.D., G.T., T.R.M., O.S.) Infectious Diseases (E.C.-B.), Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tinkhauser</LastName>
            <ForeName>Gerd</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0002-1954-1873</Identifier>
            <AffiliationInfo>
              <Affiliation>From the Departments of Neurology (A.D., G.T., T.R.M., O.S.) Infectious Diseases (E.C.-B.), Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meinel</LastName>
            <ForeName>Thomas Raphael</ForeName>
            <Initials>TR</Initials>
            <Identifier Source="ORCID">0000-0002-0647-9273</Identifier>
            <AffiliationInfo>
              <Affiliation>From the Departments of Neurology (A.D., G.T., T.R.M., O.S.) Infectious Diseases (E.C.-B.), Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scheidegger</LastName>
            <ForeName>Olivier</ForeName>
            <Initials>O</Initials>
            <Identifier Source="ORCID">0000-0003-3925-5142</Identifier>
            <AffiliationInfo>
              <Affiliation>From the Departments of Neurology (A.D., G.T., T.R.M., O.S.) Infectious Diseases (E.C.-B.), Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Neurology</MedlineTA>
        <NlmUniqueID>0401060</NlmUniqueID>
        <ISSNLinking>0028-3878</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018416" MajorTopicYN="Y">Bartonella henselae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020968" MajorTopicYN="Y">Brachial Plexus Neuritis</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002372" MajorTopicYN="Y">Cat-Scratch Disease</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002415" MajorTopicYN="N">Cats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007136" MajorTopicYN="N">Immunoglobulins</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>11</Day>
          <Hour>5</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35145008</ArticleId>
        <ArticleId IdType="pmc">PMC8992605</ArticleId>
        <ArticleId IdType="doi">10.1212/WNL.0000000000200014</ArticleId>
        <ArticleId IdType="pii">WNL.0000000000200014</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Van Eijk JJJ, Groothuis JT, Van Alfen N. Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment. Muscle Nerve.
2016;53:337-350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26662794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ripellino P, Pasi E, Melli G, et al. . Neurologic complications of acute hepatitis E virus infection. Neurol Neuroimmunol Neuroinflamm.
2020;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6935854</ArticleId>
            <ArticleId IdType="pubmed">31806684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stek CJ, van Eijk JJ, Jacobs BC, et al. . Neuralgic amyotrophy associated with Bartonella henselae infection. J Neurol Neurosurg Psychiatry.
2011;82:707-708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20710009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Florin TA, Zaoutis TE, Zaoutis LB. Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics.
2008;121(5):e1413-e1425.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18443019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canneti B, Cabo-López I, Puy-Núñez A, et al. . Neurological presentations of Bartonella henselae infection. Neurol Sci.
2019;40(2):261-268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30368695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carithers HA. Cat-scratch disease. An overview based on a study of 1,200 patients. Am J Dis Child.
1985;139(11):1124-1133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4061408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allizond V, Costa C, Sidoti F, et al. . 
Serological and molecular detection of Bartonella henselae in specimens from patients with suspected cat scratch disease in Italy: a comparative study. PLoS One.
2019;14:e0211945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6368319</ArticleId>
            <ArticleId IdType="pubmed">30735549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansmann Y, DeMartino S, Piémont Y, et al. . Diagnosis of cat scratch disease with detection of Bartonella henselae by PCR: a study of patients with lymph node enlargement. J Clin Microbiol.
2005;43:3800-3806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1233974</ArticleId>
            <ArticleId IdType="pubmed">16081914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sander A, Posselt M, Böhm N, Ruess M, Altwegg M. Detection of Bartonella henselae DNA by two different PCR assays and determination of the genotypes of strains involved in histologically defined cat scratch disease. J Clin Microbiol.
1999;37:993-997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC88638</ArticleId>
            <ArticleId IdType="pubmed">10074515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. . 
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a Joint Task Force—second revision. J Peripher Nerv Syst.
2021;26:242-268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34085743</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
